Healthcare Triangle is trading 16.63% down at $3.85 as the company faces a critical Nasdaq appeal hearing regarding its minimum-bid-price requirement.
- The hearing, scheduled for November 5, will determine whether the company can maintain its Nasdaq listing after previously failing to meet the exchange's minimum bid price standards.
- The stock's sharp decline follows a period of significant volatility, including an 11.83% drop during the November 4 session.
- While broader technology market weakness may be contributing to the downward pressure, the outcome of the delisting appeal is the primary company-specific catalyst for the move.